APOL1 Long-term Kidney Transplantation Outcomes Research Network (APOLLO). We are an APOLLO Network Clinical Centers (CCs) within this multi-center, multi-disciplinary study group following a prospective longitudinal cohort to determine the impact of APOL1 genetic variants as susceptibility factors in US kidney transplant recipients who received kidneys from African American donors. Liise Kayler (Co-Investigator). National Institutes of Diabetes and Digestive and Kidney Disease (NIDDK) of the National Institutes of Health. $229,964. 9/1/2017-9/1/2026.
Increasing Live Donor Kidney Transplantation Through Video-based Education and Mobile Communication. Liise Kayler (Co-Principal Investigator). NIH. $3,543,724. 8/1/2021-7/1/2025.
Feasibility of an eHealth Educational Intervention for African Americans with End-stage Kidney Disease. Liise Kayler (Co-Principal Investigator). University at Buffalo CTSI Award. $45,000. 5/1/2020-5/1/2022.